You searched for "ABPI"
NHS collaboration and partnership with the pharmaceutical and medical devices industries
Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...The doctor – pharmaceutical company relationship
‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...Pharma chameleon
One morning in September ’95, about a month into my first house job on the South Coast of England, I emerged from the ridiculously early ward round on the coronary care unit feeling a bit dazed and therefore headed off...Auditory brainstem implant results in adults and children
Background The auditory brainstem implant (ABI) has been developed from cochlear implant (CI) technology and is indicated for people who have anatomical abnormalities of the cochlea or dysfunction of the auditory nerve. The majority of people who have received an...
Is there hope of hearing for postmeningitic patients deemed unsuitable for a cochlear implant?
Rehabilitation of patients with profound hearing loss deemed unsuitable for cochlear implants is challenging. An auditory brainstem implant (ABI) is a viable option for these patients. This paper evaluates auditory and speech perception outcome measures following ABI in 10 postmeningitic...Paediatric auditory brainstem implant: overview and outcomes
Auditory brainstem implants were first used in adults with NF2. They have more recently become a technology option for children but what is the evidence to support this choice? This article discusses the evidence so far. Auditory brainstem implant is...Industry interaction with the ENT speciality
I was enormously grateful for the chance to articulate my personal thoughts on ‘the industry interaction with the ENT clinical community’. To set a context, the term ‘industry’ refers to medical technology manufacturers and suppliers, in addition to pharmaceutical companies....Jameel Muzaffar, Anne Schilder and James O’Hara
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...Jameel Muzaffar, Anne Schilder and James O’Hara
In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...Hearing rehabilitation after vestibular schwannoma surgery
Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...
